Infectious disease physicians at UT Health San Antonio are among the first in the nation to test an investigational drug developed to treat COVID-19.

Dr. Thomas Patterson, chief of the Division of Infectious Disease at UT Health San Antonio, will lead the study at University Hospital.

“Our nurses and doctors are very encouraged to be able to offer this antiviral, which appears to be the most active to date against the virus causing COVID-19,” he said.

Brooke Army Medical Center is also participating in the study.

Read the full story.

The post KENS 5: UT Health San Antonio joins national study to test anti-coronavirus drug in critically ill patients appeared first on UT Health San Antonio.